 I'd love to share a little bit with your listeners. Well, please do, because I know that over the past couple of years, I know there's been really, really promising breakthroughs in regards to the treatment of Alzheimer's. Can you share anything with us? I sure can. This week, actually, we had a new drug that was approved by the FDA. It had been going through the FDA process under the name of Donatumabab, but now it has a brand-new name called Kasunla,